Apart from its clinical use in imaging, ultrasound has been thoroughly investigated as a tool
to enhance drug delivery in a wide variety of applications. Therapeutic ultrasound, as such …

Since its outbreak in the last December, coronavirus disease 2019 (COVID-19) caused by
SARS-CoV-2 has rapidly spread worldwide at a pandemic proportion and thus is regarded …

PURPOSE CARTITUDE-1, a phase Ib/II study evaluating the safety and efficacy of
ciltacabtagene autoleucel (cilta-cel) in heavily pretreated patients with relapsed/refractory …

The pestilential pathogen SARS-CoV-2 has led to a seemingly ceaseless pandemic of
COVID-19. The healthcare sector is under a tremendous burden, thus necessitating the …

Multiple myeloma (MM) is a distinguished hematologic malignancy, with existing studies
elucidating its interaction with neutrophil extracellular traps (NETs), which may potentially …

Major progress has been made in the upfront treatment of multiple myeloma, but the disease
ultimately relapses and leads to death in the vast majority of those afflicted. New treatment …

Simple Summary The evolving data from trials assessing novel combinations as a part of the
frontline and relapse treatment in transplant and non-transplant candidates have markedly …

Simple Summary There are multiple processes that can go awry to drive cancer. One of
these arises from a dysregulation of trafficking of cellular materials between the two major …

Recent advances in adoptive cell therapy have considerably changed the paradigm of
cancer immunotherapy. Although current immunotherapies could cure many patients with …

Abstract Selinexor (KPT-330) is a small molecule inhibitor of XPO1, which mediates the
transport of tumor suppressor proteins, oncogene messenger RNAs, and other proteins …